<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen CW</submitter><funding>U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)</funding><funding>Ministry of Science and Technology, Taiwan</funding><funding>Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>2264</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10938004</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>NME3 is a member of the nucleoside diphosphate kinase (NDPK) family localized on the mitochondrial outer membrane (MOM). Here, we report a role of NME3 in hypoxia-induced mitophagy dependent on its active site phosphohistidine but not the NDPK function. Mice carrying a knock-in mutation in the Nme3 gene disrupting NME3 active site histidine phosphorylation are vulnerable to ischemia/reperfusion-induced infarction and develop abnormalities in cerebellar function. Our mechanistic analysis reveals that hypoxia-induced phosphatidic acid (PA) on mitochondria is essential for mitophagy and the interaction of DRP1 with NME3. The PA binding function of MOM-localized NME3 is required for hypoxia-induced mitophagy. Further investigation demonstrates that the interaction with active NME3 prevents DRP</pubmed_abstract><journal>Nature communications</journal><pubmed_title>NME3 is a gatekeeper for DRP1-dependent mitophagy in hypoxia.</pubmed_title><pmcid>PMC10938004</pmcid><funding_grant_id>NSCT 111-2326-B-002-022</funding_grant_id><funding_grant_id>CA242443</funding_grant_id><funding_grant_id>NSCT 111-2634-F-002-017</funding_grant_id><funding_grant_id>NSCT 111-2320-B-002-088</funding_grant_id><funding_grant_id>R35 CA242443</funding_grant_id><pubmed_authors>Hunter T</pubmed_authors><pubmed_authors>Su C</pubmed_authors><pubmed_authors>Feng Y</pubmed_authors><pubmed_authors>Hsieh ST</pubmed_authors><pubmed_authors>Chang ZF</pubmed_authors><pubmed_authors>Cuili X</pubmed_authors><pubmed_authors>Fan CH</pubmed_authors><pubmed_authors>Ting CW</pubmed_authors><pubmed_authors>Yeh TY</pubmed_authors><pubmed_authors>Huang CY</pubmed_authors><pubmed_authors>Tsai YW</pubmed_authors><pubmed_authors>Chen YJ</pubmed_authors><pubmed_authors>Yang KC</pubmed_authors><pubmed_authors>Huang XR</pubmed_authors><pubmed_authors>Chao T</pubmed_authors><pubmed_authors>Chen CW</pubmed_authors></additional><is_claimable>false</is_claimable><name>NME3 is a gatekeeper for DRP1-dependent mitophagy in hypoxia.</name><description>NME3 is a member of the nucleoside diphosphate kinase (NDPK) family localized on the mitochondrial outer membrane (MOM). Here, we report a role of NME3 in hypoxia-induced mitophagy dependent on its active site phosphohistidine but not the NDPK function. Mice carrying a knock-in mutation in the Nme3 gene disrupting NME3 active site histidine phosphorylation are vulnerable to ischemia/reperfusion-induced infarction and develop abnormalities in cerebellar function. Our mechanistic analysis reveals that hypoxia-induced phosphatidic acid (PA) on mitochondria is essential for mitophagy and the interaction of DRP1 with NME3. The PA binding function of MOM-localized NME3 is required for hypoxia-induced mitophagy. Further investigation demonstrates that the interaction with active NME3 prevents DRP</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-15T12:01:47.972Z</modification><creation>2026-07-04T03:12:28.459Z</creation></dates><accession>S-EPMC10938004</accession><cross_references><pubmed>38480688</pubmed><doi>10.1038/s41467-024-46385-7</doi></cross_references></HashMap>